|
Name |
Periconiasin E
|
Molecular Formula | C22H33NO3 | |
IUPAC Name* |
(1S,2S,4S,6R,9R,12S,13R,14S)-2,4-dihydroxy-7,11,12-trimethyl-14-(2-methylpropyl)-15-azatetracyclo[7.7.0.01,13.02,6]hexadeca-7,10-dien-16-one
|
|
SMILES |
C[C@H]1[C@H]2[C@@H](NC(=O)[C@@]23[C@H](C=C1C)C=C([C@@H]4[C@]3(C[C@H](C4)O)O)C)CC(C)C
|
|
InChI |
InChI=1S/C22H33NO3/c1-11(2)6-18-19-14(5)12(3)7-15-8-13(4)17-9-16(24)10-21(17,26)22(15,19)20(25)23-18/h7-8,11,14-19,24,26H,6,9-10H2,1-5H3,(H,23,25)/t14-,15-,16+,17-,18+,19+,21+,22-/m1/s1
|
|
InChIKey |
YRFACIIPVMVLPW-WAEZUTTDSA-N
|
|
Synonyms |
Periconiasin E; J3.567.281H
|
|
CAS | NA | |
PubChem CID | 132577308 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 359.5 | ALogp: | 1.9 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 69.6 | Aromatic Rings: | 4 |
Heavy Atoms: | 26 | QED Weighted: | 0.66 |
Caco-2 Permeability: | -5.283 | MDCK Permeability: | 0.00001860 |
Pgp-inhibitor: | 0.039 | Pgp-substrate: | 0.999 |
Human Intestinal Absorption (HIA): | 0.078 | 20% Bioavailability (F20%): | 0.36 |
30% Bioavailability (F30%): | 0.58 |
Blood-Brain-Barrier Penetration (BBB): | 0.755 | Plasma Protein Binding (PPB): | 75.01% |
Volume Distribution (VD): | 1.557 | Fu: | 11.57% |
CYP1A2-inhibitor: | 0.068 | CYP1A2-substrate: | 0.321 |
CYP2C19-inhibitor: | 0.238 | CYP2C19-substrate: | 0.72 |
CYP2C9-inhibitor: | 0.161 | CYP2C9-substrate: | 0.035 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.068 |
CYP3A4-inhibitor: | 0.797 | CYP3A4-substrate: | 0.336 |
Clearance (CL): | 13.379 | Half-life (T1/2): | 0.162 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.48 |
Drug-inuced Liver Injury (DILI): | 0.075 | AMES Toxicity: | 0.134 |
Rat Oral Acute Toxicity: | 0.916 | Maximum Recommended Daily Dose: | 0.887 |
Skin Sensitization: | 0.233 | Carcinogencity: | 0.117 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.019 |
Respiratory Toxicity: | 0.977 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003806 | 0.707 | D0E9KA | 0.267 | ||||
ENC003434 | 0.549 | D0F1EX | 0.239 | ||||
ENC004242 | 0.510 | D03IKT | 0.239 | ||||
ENC005825 | 0.500 | D0D2TN | 0.233 | ||||
ENC002049 | 0.495 | D08PIQ | 0.233 | ||||
ENC005136 | 0.495 | D0W2EK | 0.224 | ||||
ENC004462 | 0.480 | D0C8HR | 0.221 | ||||
ENC001855 | 0.480 | D04SFH | 0.221 | ||||
ENC002636 | 0.480 | D06WTZ | 0.220 | ||||
ENC003740 | 0.471 | D00GOS | 0.218 |